S-Biomedics Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
55
- Stock Symbol
-
304360
- Share Price
-
$13.99
- (As of Friday Closing)
S-Biomedics General Information
Description
S Biomedics Co Ltd is engaged in development, manufacturing and supply of stem cell treatment products, and main business is the production and sale of pharmaceutical products.
Contact Information
Website
www.sbiomedics.comCorporate Office
- Office Building, Research Building, 320
- Munbal-ro, Munbal-dong
- Paju, Gyeonggi 10881
- South Korea
Corporate Office
- Office Building, Research Building, 320
- Munbal-ro, Munbal-dong
- Paju, Gyeonggi 10881
- South Korea
S-Biomedics Stock Performance
As of 13-Nov-2026, S-Biomedics’s stock price is $13.99. Its current market cap is $173M with 12.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $13.99 | $14.10 | $9.56 - $29.42 | $173M | 12.4M | 21.8K | -$0.68 |
S-Biomedics Financials Summary
As of 30-Jun-2026, S-Biomedics has a trailing 12-month revenue of $11.4M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 177,556 | 317,549 | 140,215 | 102,738 |
| Revenue | 11,364 | 11,628 | 10,066 | 10,026 |
| EBITDA | (5,495) | (2,589) | (2,600) | (5,326) |
| Net Income | (8,309) | (5,707) | (4,904) | (7,894) |
| Total Assets | 49,226 | 28,624 | 30,279 | 24,791 |
| Total Debt | 11,296 | 8,476 | 12,751 | 9,308 |
S-Biomedics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
S-Biomedics Patents
S-Biomedics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4682546-A1 | Liquid handling device | Pending | 15-Mar-2023 | ||
| EP-4682546-A4 | Liquid handling device | Pending | 15-Mar-2023 | ||
| US-20250375762-A1 | Liquid handling device | Pending | 15-Mar-2023 | ||
| WO-2024190997-A1 | Liquid handling device | Inactive | 15-Mar-2023 | ||
| AU-2022216137-A1 | Method for inducing and preparing retinal outer layer cells from stem cells, and composition for preventing or treating retinal diseases, containing cells prepared thereby | Active | 02-Feb-2021 | C12N5/0621 |
S-Biomedics Signals
S-Biomedics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
S-Biomedics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Commercial Services
Industry
Rank
Percentile
Business Support Services
Subindustry
Rank
Percentile
S-Biomedics FAQs
-
When was S-Biomedics founded?
S-Biomedics was founded in 2005.
-
Where is S-Biomedics headquartered?
S-Biomedics is headquartered in Paju, South Korea.
-
What is the size of S-Biomedics?
S-Biomedics has 55 total employees.
-
What industry is S-Biomedics in?
S-Biomedics’s primary industry is Drug Discovery.
-
Is S-Biomedics a private or public company?
S-Biomedics is a Public company.
-
What is S-Biomedics’s stock symbol?
The ticker symbol for S-Biomedics is 304360.
-
What is the current stock price of S-Biomedics?
As of 13-Nov-2026 the stock price of S-Biomedics is $13.99.
-
What is the current market cap of S-Biomedics?
The current market capitalization of S-Biomedics is $173M.
-
What is S-Biomedics’s current revenue?
The trailing twelve month revenue for S-Biomedics is $11.4M.
-
What is S-Biomedics’s annual earnings per share (EPS)?
S-Biomedics’s EPS for 12 months was -$0.68.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process